NeuroStar Advanced TMS Therapy Provides an Alternative to Antidepressants
Transcranial magnetic stimulation (TMS) is a safe, effective, non-invasive treatment that uses magnetic pulses to stimulate neural networks in the brain. The treatment is proven to improve the symptoms of depression without the risk of long-term side effects, unlike many anti-depressant medications.
During TMS, pulses are aimed at the structures in the brain associated with mood regulation. The pulses are dynamic and rapidly changing, which induces electrical charges to flow, only creating a small amount of electricity. These small electric charges cause neurons to activate or fire, stimulating inactive brain cells, alleviating depression symptoms.
During treatment sessions that last approximately 30 minutes, patients are encouraged to relax in a reclined chair. There’s little to no downtime and patients can drive to and from treatments on their own. Our patients comfortably chat with our staff or listen to music while receiving treatment.
1822 North Main Street
Suite 6
Fall River, MA, 02720
© NeuroHealth Consulting 2024 | All Rights Reserved | Privacy Policy
Indication
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary. The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode. The NeuroStar Advanced Therapy system is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD). Visit neurostar.com for full safety and prescribing information.
Important Safety Information
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient). NeuroStar Advanced Therapy should not be used with patients who have non-removable conductive metal in or near the head. NeuroStar Advanced Therapy has not been studied in patients who have not received prior antidepressant treatment.
